Johnson & Johnson delays Covid vaccine rollout in Europe as US regulator investigates blood clot risk ...News

Russia Today - News
Johnson & Johnson delays Covid vaccine rollout in Europe as US regulator investigates blood clot risk
Johnson & Johnson said it will “proactively delay” the rollout of its Covid-19 vaccine in Europe after US regulators announced an investigation into the risk of blood clots among people who receive the jab. In a statement released by the company on Tuesday, Johnson & Johnson said it will pause the rollout of the vaccine in Europe “out of an abundance of caution” after the US Centers for Disease Control (CDC) and Food and Drug Administration (FDA) announced an investigation into the risk of blood clots as a potential side effect. While cases of blood clots reported among its recipients in the US have been very rare – with only six cases

Hence then, the article about johnson johnson delays covid vaccine rollout in europe as us regulator investigates blood clot risk was published today ( ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Johnson & Johnson delays Covid vaccine rollout in Europe as US regulator investigates blood clot risk )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News